Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 195 results for "orchid chemicals and pharmaceuticals"

Exit Orchid Chemicals on rallies: Mayuresh Joshi

According to Mayuresh Joshi, VP- Institution at Angel Broking, one may exit Orchid Chemicals and Pharmaceuticals on rallies. Money Control, 4 weeks ago
Exit Orchid Chemicals, says Kunal Saraogi Money Control, 4 weeks ago

Orchid Chemicals net loss increases to Rs.60 cr in Q3

Orchid Chemicals and Pharmaceuticals has suffered setback during the third quarter ended June 2014 and its net loss increased to Rs. 60.14 crore from Rs. 54.50 crore in the corresponding period of last year despite net sales growth of 12.1 per cent ...
 PharmaBiz1 month ago Orchid Chemicals & Pharmaceuticals reports net loss of Rs 60.14 crore in the June 2014 quarter  Business Standard1 month ago Orchid Pharma registers turnover of Rs 285 crore in Q3 FY14  Noodls1 month ago

Orchid Chemicals & Pharmaceuticals to hold board meeting

This page uses frames, but your browser doesn't
 Capital Market1 month ago

New Report Available: Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014

Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014', provides an overview of the Orchid Chemicals & Pharmaceuticals ...
 Town Hall3 weeks ago New Market Research Report: Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014  Town Hall2 weeks ago New Report Available Orchid ChemicalsPharmaceuticals Ltd - Product Pipeline Review - 2014  MENAFN3 weeks ago Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014  Town Hall1 month ago
[x]  

Orchid Chemicals & Pharmaceuticals announces US FDA approval for Eszopiclone Tablets ANDA

Capital Market June 20, 2014 Last Updated at 11:01 IST Related News Orchid Chemicals & Pharmaceuticals holds AGM Orchid Chemicals & Pharmaceuticals CDR proposal approved Orchid Chemicals & Pharmaceuticals extends AGM time limit On 19 June 2014 Orchid ...
 Business Standard2 months ago Orchid Chemicals up 8% on USFDA nod for insomnia drug  Money Control2 months ago Orchid gets USFDA approval for Eszopiclone tablets ANDA  Myiris2 months ago Orchid receives USFDA approval for Eszopiclone tablets ANDA  Money Control2 months ago

Orchid Chem jumps on USFDA nod for Eszopiclone tablets

The Orchid Chemicals & Pharmaceuticals' shares jumped on Friday after the company has received approval from the USFDA for its ANDA (abbreviated new drug application) for Eszopiclone Tablets, 1 mg, 2 mg and 3 mg strengths. Shares of the company are trading at ...
 Myiris2 months ago Orchid Chemicals jumps on USFDA nod for a medicine  India Infoline2 months ago

07.15.14 -- Lilly and Yabao To Partner For Diabetes Therapy; Hospira Acquires Orchid

SPONSOR Outsourced Pharma West Conference And Exhibition November 10 and 11, 2014 | Hyatt Regency, San Francisco, CA • Who should attend? Pharma and biopharm executives who form and manage outsourcing partnerships. ...
 Pharmaceutical Online2 months ago Orchid Chem hits 52-wk high, up 3%; seals deal with Hospira  Money Control2 months ago Hospira complets acquisition of Orchid Pharma's facilities  Business Standard2 months ago Orchid completes Hospira deal, implementation of CDR package  Business Standard2 months ago
Business Standard India

Pharma shares on a roll; BSE Healthcare index up 3%

Cipla, Sun Pharma, Lupin, Cadila Healthcare, Aurobindo and Glenmark are up 2-4%, quoting at their lifetime highs. Deepak Korgaonkar | Mumbai August 20, 2014 Last Updated at 13:27 IST Shares of pharmaceutical companies are on a roll with most of the ...
 Business Standard India4 weeks ago

Hospira Upgraded to Strong Buy on Orchid Facility Buy

On Jul 12, Zacks Investment Research upgraded Hospira Inc. ( HSP ) to a Zacks #1 Rank (Strong Buy). Why the Upgrade? The upgrade came on the heels of Hospira's recently completed Orchid facility buy. Earlier in the month, the company announced ...
 Yahoo! Finance2 months ago
PR Newswire

Hospira Reports Second-Quarter 2014 Results

"Hospira delivered another strong quarter, driven by continued positive performance in our Specialty Injectable Pharmaceuticals products," said F. Michael Ball , chief executive officer. "The investments we have been making to reinforce our ...
 Morningstar.com1 month ago Hospira's (HSP) CEO Michael Ball on Q2 2014 Results - Earnings Call Transcript  Seeking Alpha1 month ago Hospira Raises Guidance  Earnings Whispers1 month ago Hospira, Inc. Reports Second-Quarter 2014 Results  BioSpace1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - orchid chemicals and pharmaceuticals
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less